🇺🇸 FDA
Patent

US 9267139

Compositions and methods for treating musculoskeletal diseases and disorders

granted A61KA61K31/713A61K35/28

Quick answer

US patent 9267139 (Compositions and methods for treating musculoskeletal diseases and disorders) held by Georgia Regents Research Institute, Inc. expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Georgia Regents Research Institute, Inc.
Grant date
Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/713, A61K35/28